Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Cytomx Thera (CTMX)

20.16 +0.07 (+0.35%)

10/20/2017  4:00pm

Open:

20.07

Pre. Close:

20.09

High:

20.62

Low:

19.88

Volume:

253,534

Market Cap:

743.24M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

21.74 - 21.74

21.74 - 21.75

Low:

18.81 - 19.02

19.02 - 19.33

Close:

19.29 - 19.71

19.71 - 20.33

Technical analysis  (as of: 2017-10-20 4:35:01 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 25.40     One year: 28.82

Support:

Support1: 17.02    Support2: 14.16

Resistance:

Resistance1: 21.75    Resistance2: 24.67

Pivot:

20.92

Moving Averages:

MA(5): 20.25     MA(20): 20.15

MA(100): 16.09     MA(250): 14.41

MACD:

MACD(12,26): 0.81     Signal(12,26,9): 1.07

%K %D:

%K(14,3): 32.06     %D(3): 36.34

RSI:

RSI(14): 55.51

52-Week:

High: 24.67  Low: 9.85  Change(%): 60.5

Average Vol(K):

3-Month: 29900  10-Days 13871

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CTMX has closed above bottom band by 32.3%. Bollinger Bands are 32.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 13 Oct 2017 15:56:15 GMT
Commit To Buy CytomX Therapeutics At $17.50, Earn 15.4% Annualized Using Options

Mon, 02 Oct 2017 21:30:05 GMT
CytomX Therapeutics Inc. (CTMX) Soars 5.94% on October 02

Sat, 21 Oct 2017 12:33:45 GMT
Fmr LLC Has $85.44 Million Stake in CytomX Therapeutics, Inc. (NASDAQ:CTMX)

Thu, 05 Oct 2017 21:30:08 GMT
CytomX Therapeutics Inc. (CTMX) Moves Lower on Volume Spike for October 05

Tue, 17 Oct 2017 12:11:15 GMT
Major Analyst Actions Under Review: CytomX Therapeutics, Inc. (CTMX), Aqua ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

27.49

% Held by Insiders

7.90

% Held by Institutions

76.18

Shares Short (K)

1180

Shares Short Prior Month (K)

1210

Stock Financials

EPS

-1.700

EPS Est. Current Year

-1.470

EPS Est. Next Year

-1.380

EPS Est. Next Quarter

-0.410

Forward EPS

-1.510

Book Value (p.s.)

1.420

PEG Ratio

-8.10

Profit Margin

-206.33

Operating Margin

-209.53

Return on Assets (ttm)

-14.1

Return on Equity (ttm)

-81.0

Qtrly Rev. Growth

182.9

Gross Profit (p.s.)

0.408

Sales Per Share

EBITDA (p.s.)

-1.666

Qtrly Earnings Growth

Operating Cash Flow (M)

141.86

Levered Free Cash Flow (M)

7.01

FoxReading.com

Valuation

P/E

-11.86

P/E Growth Ratio

P/BV

14.20

P/S

906462400.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.